Preventing Recurrent Stroke: Evidence-based Approach to Antiplatelet Agents

Drs. Jan Basile and Philip Gorelick discuss the Population Attributable Risk (PAR), which stroke risk factor has the highest risk for stroke and why this is so important, and the use of antiplatelet agents in preventing recurrent stroke according to the 2011 updated AHA Guidelines.   Recorded November 4, 2011 in Williamsburg, Virginia.


You must be logged in to access this podcast.

Share This:
  • Print
  • Digg
  • Facebook
  • Google Bookmarks
  • email
  • LinkedIn
  • Twitter
  • HealthRanker
  • StumbleUpon
  • Yahoo! Buzz

Leave a Reply